Michael Joseph Driscoll - 21 Feb 2024 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Director
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
21 Feb 2024
Transactions value $
$0
Form type
4
Filing time
23 Feb 2024, 17:21:21 UTC
Previous filing
24 Feb 2023
Next filing
21 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Award $0 +51K +55.89% $0.00 142K 21 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in full on February 15, 2025.